Cholangiocarcinoma (CCA) is a rare cancer1 and there are few resources directed at patients, therefore a diagnosis of CCA can be worrying and confusing. Help your patients navigate through the uncertainty by providing them with resources about their disease.
Listen to Professor Jesús Bañales describe the devastating impact of CCA and how access to specifically tailored CCA resources can benefit your patients. Please note, available resources vary by country.
REFERENCE: 1. Bañales JM, et al. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.
Supported by an independent educational grant from Incyte, ‘Clinical advances in the treatment of CCA’ is a Medscape educational initiative that provides a broad range of Continuing Medical Education (CME)-accredited activities to inform on the identification, diagnosis and treatment of patients with CCA. The fifth and final activity is now live and educates healthcare professionals on best practice treatment of advanced/metastatic CCA through interactive case studies and expert perspectivesView resource
Vogel A, et al. Ann Oncol. 2023;34:127–40.
Banales JM, et al. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.
Kodali S, et al. J Clin Med. 2021;10:2368.
Yang W, Sun Y. Onco Targets Ther. 2021;14:1341–66.
Bekaii-Saab TS, et al. Ann Oncol. 2021;32:1111–26.
Valle JW, et al. Lancet. 2021;397:428–44.
Incyteful is an Incyte platform that offers CCA medical education and events relevant to your daily practice
Incyteful is your one-stop resource for:
Register now and gain access to Incyteful, your educational hub for CCA*
*Incyteful is intended for Healthcare Professionals in one of the member states of the European Union or the United Kingdom only. Incyteful may not currently be available in your country